Advances in the surgical treatment of heart failure

Current Opinion in Cardiology

Volumn 23, Issue 3, 2008, Pages 249-253

  Allen, Larry A ^a   Felker, G Michael ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Heart failure; Mitral valve; Surgery; Ventricular assist device

Indexed keywords

CORONARY ARTERY BYPASS GRAFT; DEVICE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; MITRAL VALVE REGURGITATION; ORGAN DONOR; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY BYPASS; EVIDENCE-BASED MEDICINE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY;

EID: 41749109155     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e3282f54fea     Document Type: Review

References (35)

1. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult-Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 2005; 112:1825-1852.
2. ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery. Circulation 2004; 110:e340-e437.
3. Alderman EL, Bourassa MG, Cohen LS, et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation 1990; 82:1629-1646.
4. Velazquez EJ, Lee KL, O'Connor CM, et al. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg 2007; 134:1540-1547. This paper summarizes the rationale and design of the landmark STICH study, which will address fundamental questions in the surgical approach to patients with ischemic heart disease and heart failure.
5. Athanasuleas CL, Buckberg GD, Stanley AWH, et al. Surgical ventricular restoration in the treatment of congestive heart failure due to postinfarction ventricular dilation. J Am Coll Cardiol 2004; 44:1439-1445.
6. Hernandez AF, Velazquez EJ, Dullum MK, et al. Contemporary performance of surgical ventricular restoration procedures: data from the Society of Thoracic Surgeons' National Cardiac Database. Am Heart J 2006; 152:494-499.
7. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report - 2007. J Heart Lung Transplant 2007; 26:769-781.
8. Deng MC, Smits JM, Young JB. Proposition: the benefit of cardiac transplantation in stable outpatients with heart failure should be tested in a randomized trial. J Heart Lung Transplant 2003; 22:113-117.
9. Felker GM, Milano CA, Yager JE, et al. Outcomes with an alternate list strategy for heart transplantation. J Heart Lung Transplant 2005; 24:1781-1786.
10. Zaroff JG, Rosengard BR, Armstrong WF, et al. Consensus Conference Report: Maximizing use of organs recovered from the cadaver donor: Cardiac Recommendations March 28-29, 2001, Crystal City, VA. Circulation 2002; 106:836-841.
11. Aaronson KD, Eppinger MJ, Dyke DB, et al. Left ventricular assist device therapy improves utilization of donor hearts. J Am Coll Cardiol 2002; 39:1247-1254.
12. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long term use of left-ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345:1435-1443.
13. Rogers JG, Butler J, Lansman SL, et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol 2007; 50:741-747. Although nonrandomized, this study replicated the findings of the REMATCH study in an independent population using a different device, establishing the generalizability of destination therapy.
14. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007; 357:885-896. This is the first substantial published experience with the 'next generation' axial flow pump VAD design, which has several potential advantages over traditional VAD technology.
15. Baughman KL, Jarcho JA. Bridge to life - cardiac mechanical support. N Engl J Med 2007; 357:846-849.
16. Stevenson LW, Miller LW, Desvigne-Nickens P, et al. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation 2004; 110:975-981.
17. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007; 116:497-505. This study represents the first effort to comprehensively identify markers of risk in patients undergoing destination LVAD therapy.
18. Stevenson LW, Couper G. On the fledgling field of mechanical circulatory support. J Am Coll Cardiol 2007; 50:748-751.
19. Otto CM. Evaluation and management of chronic mitral regurgitation. N Engl J Med 2001; 345:740-746.
20. Hueb AC, Jatene FB, Moreira LF, et al. Ventricular remodeling and mitral valve modifications in dilated cardiomyopathy: new insights from anatomic study. J Thorac Cardiovasc Surg 2002; 124:1216-1224.
21. Perloff JK, Roberts WC. The mitral apparatus. Functional anatomy of mitral regurgitation. Circulation 1972; 46:227-239.
22. D'Cruz IA, Shroff SG, Janicki JS, et al. Differences in the shape of the normal, cardiomyopathic, and volume overloaded human left ventricle. J Am Soc Echocardiogr 1989; 2:408-414.
23. Trichon BH, Felker GM, Shaw LK, et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 2003; 91:538-543.
24. Cabell CH, Trichon BH, Velazquez EJ, et al. Importance of echocardiography in patients with severe nonischemic heart failure: the second Prospective Randomized Amlodipine Survival Evaluation (PRAISE-2) echocardiographic study. Am Heart J 2004; 147:151-157.
25. Breithardt OA, Sinha AM, Schwammenthal E, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003; 41:765-770.
26. Lowes BD, Gill EA, Abraham WT, et al. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol 1999; 83:1201-1205.
27. Stevenson LW, Bellil D, Grover-McKay M, et al. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1987; 60:654-658.
28. Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 1998; 115:381-386.
29. Mann DL, Acker MA, Jessup M, et al. Clinical evaluation of the CorCap cardiac support device in patients with dilated cardiomyopathy. Ann Thorac Surg 2007; 84:1226-1235.
30. Acker MA, Bolling S, Shemin R, et al. Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. J Thorac Cardiovasc Surg 2006; 132:568-577. This paper summarizes the results of the Acorn study related to the impact of mitral valve repair and represents the most contemporary controlled experience with this therapy in heart failure.
31. Levine RA, Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation 2005; 112:745-758.
32. Messas E, Guerrero JL, Handschumacher MD, et al. Chordal cutting: a new therapeutic approach for ischemic mitral regurgitation. Circulation 2001; 104:1958-1963.
33. Rankin JS, Hammill BG, Ferguson TB Jr, et al. Determinants of operative mortality in valvular heart surgery. J Thorac Cardiovasc Surg 2006; 131:547-557.
34. Shah AS, Hannish SA, Milano CA, Glower DD. Isolated mitral valve repair in patients with depressed left ventricular function. Ann Thorac Surg 2005; 80:1309-1314.
35. Bach DS, Bolling SF. Improvement following correction of secondary mitral regurgitation in end-stage cardiomyopathy with mitral annuloplasty. Am J Cardiol 1996; 78:966-969.